Peer Review History

Original SubmissionMay 5, 2021
Decision Letter - Juan J Loor, Editor

PONE-D-21-14932

Gut microbiota features associated with Clostridioides difficile colonization in dairy calves

PLOS ONE

Dear Dr. Redding,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

PLEASE ADDRESS THE COMMENTS OF THE REVIEWERS IN THE REVISED VERSION.

Please submit your revised manuscript by Oct 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works.

- https://doi.org/10.1016/j.anaerobe.2021.102353

- https://doi.org/10.1371/journal.pone.0215497

We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable, even for works which you authored. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications.

Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work.

We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a very well written manuscript that presents interesting findings regarding C. diff in dairy calves and I only have minor comments to be addressed.

L62: Please provide additional details for the "manual" sample collection as this is not widely known by PlosOne readers (or provide a reference). Please include the amount of material that was collected, were samples processed the same day, shipping conditions, time in transport, etc. You state calves were less than 2-wk-of-age, but Figure 1 shows data from calves aged 21-22 days. Please clarify. Does the animal protocol number need to be included in the text?

Reviewer #2: Overall, the authors present a study with pertinence to the dairy industry and the results have potential implications for advancing our understanding of the fecal microbiota for benefiting calf health.

In reference to the technical soundness of this manuscript, the sequencing and analysis methods appear adequate; however, details are missing that are required for evaluation of this manuscript. Positive and negative controls should be listed for the DNA extraction kit and PCR; additionally, PCR specification details should be included. The authors should also substitute "microbiota" for "microbiome" throughout the manuscript, as they did not include any whole genome sequencing data. Also, the authors should comment on the accuracy of the Xpert kit used for C diff diagnosis with appropriate references included. In terms of the conclusions being supported by the data included, more clarity in the results section is needed. For example, one of the major findings is that farm location explained most of the variation of the fecal microbiota composition (ln 141-143). Figure 3 and 4 are both referenced in ln 141-143; however, Fig 3 doesn't illustrate this result of farm variability, as Bray-Curtis and unweighted UniFrac are shown for all C. diff + and C. diff - calves. The y axes for Figure 3a and 3b should also be labeled to improve clarity in this figure. Figure 4 should have a legend explaining the breakdown of colors and farm ID; clustering by farm should also be indicated on the PCA plot.

In terms of the methods/statistical analysis, sample size calculations should be included. Additionally, the method for selecting "healthy" calves should be included, specifically whether there were exclusion criteria. The authors should also be specific regarding whether they are referring to "relative abundance" when they indicate "abundance" or "levels" of taxa throughout the manuscript. Additionally, in line 127 the authors mention calculation of odds ratios for whether calf age or feeding waste milk was associated with the likelihood of detecting C. diff. This was not included in the methods section and this was not listed as a study objective. Also, the authors mention a mixed-effects ANOVA in line 136-141 that was not explained in the methods/statistical analysis section.

The authors did not include whether the raw sequence data had been submitted to NCBI SRA. If not available publicly, the raw abundance data should be listed as supplementary information for the manuscript.

Overall, the manuscript is written clearly; however, some errors need to be corrected. Please see individual line comments:

Ln 57: classify the study type (cross-sectional is stated in the discussion)

Ln 125: Consider revising to: "There were no farms where all samples were qPCR-negative and the pooled sample from the farm was positive". (“but” makes it sound like the pooled samples were positive)

Ln 127: Both factors (age and waste milk feeding) are not illustrated in Figure 1; consider revising

Ln 130: The authors should explain why 87 are listed instead of 92

Ln 133: Denominator is 80 for the calves that were sequenced and Figure 1 has 92 calves. Consider removing the “(Fig 1)” reference

Ln 136-141: move to methods section

Ln 141 and throughout: microbiota should be substituted for microbiota

Ln 142,143,146: revise R2 formatting to R^2

Ln 152-154: should be in a results/discussion section or moved to the discussion section

Ln 167-168: should be in the discussion or in a results/discussion section

Ln 169: Please clarify whether “all levels of abundance” refers to the resolution of taxa levels.

Ln 186-187 and throughout: Consider explaining why the fecal microbiota is representative of the gut microbiota or indicate why the complexity of the gut microbiota may not be captured with one fecal sample. Reference 31 evaluated the rumen microbiota, which may be distinct from findings in the fecal microbiota.

Ln 205: The distinction between disrupted and dysbiotic microbiota should be clarified.

Ln 223-255: Please add a citation/explanation as to why LEfSe analysis is weaker than ANCOM

Ln 239: The use of "they" pronoun is confusing. Consider revising to "it is unclear why the relative abundance of Butyricioccus was higher in..."

Ln 240-243: Please revise run-on sentence

Ln 245: genuses should be revised to genera

Ln 436: Microbiota should be substituted for microbiome. The results section indicates that 80 calves were sequenced. The correct denominator should be included with the breakdown of positive and negative C diff statuses in the figure legend. Whether 80 or 86 calves were sequenced should be consistent in all of the figure legends.

Ln 439: Same comments as above. The Y axis for Fig 3a and 3b is not labeled. Additionally, the number of positive C. diff and negative C. diff calves should be consistent in 3a and 3b. If not the authors should explain why they are different.

Ln 442: Explain in the figure legend how each color represents a different farm sampling location.

Figure 7: If there are only the taxa with mean RA > 1% included in the heat map, shouldn’t only 19 be listed based on Ln 160?. 21 are listed for C diff negative and 20 are listed for C diff positive calves. Please clarify.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1: This is a very well written manuscript that presents interesting findings regarding C. diff in dairy calves and I only have minor comments to be addressed.

AU: Thank you for your kind comments and your thorough review.

L62: Please provide additional details for the "manual" sample collection as this is not widely known by PlosOne readers (or provide a reference). Please include the amount of material that was collected, were samples processed the same day, shipping conditions, time in transport, etc. You state calves were less than 2-wk-of-age, but Figure 1 shows data from calves aged 21-22 days. Please clarify. Does the animal protocol number need to be included in the text?

AU: Manual sample collection was defined in the methods section, and additional information on transport and storage of processing. IACUC Protocol # was added. Thank you for pointing out the error with the age. The methods should say “3 weeks of age” or younger – we have corrected it.

Reviewer #2: Overall, the authors present a study with pertinence to the dairy industry and the results have potential implications for advancing our understanding of the fecal microbiota for benefiting calf health.

In reference to the technical soundness of this manuscript, the sequencing and analysis methods appear adequate; however, details are missing that are required for evaluation of this manuscript.

- Positive and negative controls should be listed for the DNA extraction kit and PCR; additionally, PCR specification details should be included.

AU: We added details regarding positive and negative PCR controls in addition to PCR specifications to the methods section.

- The authors should also substitute "microbiota" for "microbiome" throughout the manuscript, as they did not include any whole genome sequencing data.

AU: This was done.

- Also, the authors should comment on the accuracy of the Xpert kit used for C diff diagnosis with appropriate references included.

AU: Assay performance in humans and dogs has been added. Unfortunately, this assay has not been validated for use in bovine feces. This has also been added as a limitation in the discussion section.

- In terms of the conclusions being supported by the data included, more clarity in the results section is needed. For example, one of the major findings is that farm location explained most of the variation of the fecal microbiota composition (ln 141-143). Figure 3 and 4 are both referenced in ln 141-143; however, Fig 3 doesn't illustrate this result of farm variability, as Bray-Curtis and unweighted UniFrac are shown for all C. diff + and C. diff - calves. The y axes for Figure 3a and 3b should also be labeled to improve clarity in this figure.

AU: We amended the phrase to say “Farm location rather than C. difficile status” so that the references to Fig. 3 and Fig 4 still apply (i.e., Fig 3 shows that C. difficile status was NOT significantly associated with beta diversity). Y-axis labels were added to both figures.

- Figure 4 should have a legend explaining the breakdown of colors and farm ID; clustering by farm should also be indicated on the PCA plot.

AU: We added a legend to the main figure and added a supplemental figure that draws ellipses (95% confidence intervals) around samples from the same farm to show that samples tend to cluster by farm..

- In terms of the methods/statistical analysis, sample size calculations should be included. Additionally, the method for selecting "healthy" calves should be included, specifically whether there were exclusion criteria.

AU: Information on both sample sizes and selection of healthy calves was added to the M&M section.

- The authors should also be specific regarding whether they are referring to "relative abundance" when they indicate "abundance" or "levels" of taxa throughout the manuscript.

AU: We meant relative abundance throughout and have clarified in the manuscript.

- Additionally, in line 127 the authors mention calculation of odds ratios for whether calf age or feeding waste milk was associated with the likelihood of detecting C. diff. This was not included in the methods section and this was not listed as a study objective. Also, the authors mention a mixed-effects ANOVA in line 136-141 that was not explained in the methods/statistical analysis section.

AU: This missing information was added to the methods section, and the reference to ANOVA was removed, as it was in fact the linear mixed effects model that was used, and not ANOVA.

- The authors did not include whether the raw sequence data had been submitted to NCBI SRA. If not available publicly, the raw abundance data should be listed as supplementary information for the manuscript.

AU: The raw sequence data have been deposited and an SRA number provided.

Overall, the manuscript is written clearly; however, some errors need to be corrected. Please see individual line comments:

Ln 57: classify the study type (cross-sectional is stated in the discussion)

AU: this was clarified.

Ln 125: Consider revising to: "There were no farms where all samples were qPCR-negative and the pooled sample from the farm was positive". (“but” makes it sound like the pooled samples were positive)

AU: Amended. Thank you for the suggestion.

Ln 127: Both factors (age and waste milk feeding) are not illustrated in Figure 1; consider revising

AU: Milk feeding was not illustrated in Figure 1 because it was a farm-level parameter, whereas age and C. difficile-status were individual calf parameters.

Ln 130: The authors should explain why 86 are listed instead of 92.

AU: the discrepancy in numbers has been explained in the results section and figure legends have been corrected. “87 samples were sequenced, but only 80 were included in the statistical analyses and figures due to sequencing depth and unknown C. diff status from PCR.”

Ln 133: Denominator is 80 for the calves that were sequenced and Figure 1 has 92 calves. Consider removing the “(Fig 1)” reference

AU: The Fig. 1 reference was removed from here. You are correct that Figure 1 reflects the entire cohort.

Ln 136-141: move to methods section

AU : removed.

Ln 141 and throughout: microbiota should be substituted for microbiota

AU: Assuming you meant “microbiome”, we switched all instances of “microbiome” to “microbiota”

Ln 142,143,146: revise R2 formatting to R^2

AU: Changed – thanks for pointing out this formatting error.

Ln 152-154: should be in a results/discussion section or moved to the discussion section

AU: This was rephrased.

Ln 167-168: should be in the discussion or in a results/discussion section

AU: This was rephrased.

Ln 169: Please clarify whether “all levels of abundance” refers to the resolution of taxa levels.

AU: this phrase was referring to the general levels only, but because it appeared confusing, we removed it.

Ln 186-187 and throughout: Consider explaining why the fecal microbiota is representative of the gut microbiota or indicate why the complexity of the gut microbiota may not be captured with one fecal sample. Reference 31 evaluated the rumen microbiota, which may be distinct from findings in the fecal microbiota.

AU: The lack of representativeness of the fecal microbiota for the rest of the GI tract has been noted as a limitation of this study in the discussion section.

Ln 205: The distinction between disrupted and dysbiotic microbiota should be clarified.

AU: short definitions of the two terms have been provided in this section.

Ln 223-255: Please add a citation/explanation as to why LEfSe analysis is weaker than ANCOM

AU: an explanation and a citation have been added: “which suggests that the association is likely relatively weak, as a stronger association would more likely have been consistently found across multiple metrics of differential abundance (46)”.

Ln 239: The use of "they" pronoun is confusing. Consider revising to "it is unclear why the relative abundance of Butyricioccus was higher in..."

AU: amended as suggested.

Ln 240-243: Please revise run-on sentence

AU: Revised as suggested.

Ln 245: genuses should be revised to genera

AU: revised.

Ln 436: Microbiota should be substituted for microbiome. The results section indicates that 80 calves were sequenced. The correct denominator should be included with the breakdown of positive and negative C diff statuses in the figure legend. Whether 80 or 86 calves were sequenced should be consistent in all of the figure legends.

AU: The substitution has been made, and corrections have been made to the figure legends.

Ln 439: Same comments as above. The Y axis for Fig 3a and 3b is not labeled. Additionally, the number of positive C. diff and negative C. diff calves should be consistent in 3a and 3b. If not the authors should explain why they are different.

AU: Y axes were added, and figure legends were corrected to ensure consistency.

Ln 442: Explain in the figure legend how each color represents a different farm sampling location.

AU: a more complete legend was included, which should explain the color scheme clearly.

Figure 7: If there are only the taxa with mean RA > 1% included in the heat map, shouldn’t only 19 be listed based on Ln 160?. 21 are listed for C diff negative and 20 are listed for C diff positive calves. Please clarify.

AU: Thank you for pointing this out. We believe this is a rounding error, and that the Dice index was for taxa with mean RA equal to or greater than 1%. The figure legend has been adapted accordingly.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Juan J Loor, Editor

Gut microbiota features associated with Clostridioides difficile colonization in dairy calves

PONE-D-21-14932R1

Dear Dr. Redding,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed my concerns.

There is still one minor inconsistency: Line 27 of the abstract should be corrected and changed to less than 3 weeks of age. Once this has been done the paper is acceptable for publication.

Reviewer #2: The authors adequately answered all of the reviewer comments and made the necessary revisions. I think the manuscript is well-written in its current form.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Juan J Loor, Editor

PONE-D-21-14932R1

Gut microbiota features associated with Clostridioides difficile colonization in dairy calves

Dear Dr. Redding:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Juan J Loor

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .